Dabitrin (Dabigatran Etexilate Mesilate)

Dabigatran is a widely used direct thrombin inhibitor belonging to the class of anticoagulant (“blood thinner”) medications. It works by blocking thrombin, a key clotting protein, helping prevent blood clots from forming or growing. This targeted mechanism supports healthy blood flow and reduces the risk of serious complications such as stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE).

Dabigatran is approved for several critical uses, including:

• Preventing stroke and systemic embolism in adults with non‑valvular atrial fibrillation
• Treating DVT and PE after initial injectable anticoagulation
• Preventing recurrent DVT or PE in adults and children
• Preventing DVT and PE following hip replacement surgery

This category includes oral capsules and oral pellets in multiple strengths (including 75 mg, 110 mg, 150 mg), with pediatric options available in lower dosages. These formulations provide flexible dosing for initiation, treatment, and long‑term prevention. All Dabigatran products offered in this category are manufactured by reputable pharmaceutical providers to ensure potency, safety, and consistency. Whether preventing stroke in atrial fibrillation or treating existing blood clots, Dabigatran plays a vital role in modern anticoagulation therapy.